tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Sarcoidosis D012507 13 associated lipids
Hepatolenticular Degeneration D006527 3 associated lipids
Hyperglycemia D006943 21 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Burns D002056 34 associated lipids
Inflammation D007249 119 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Reyes J et al. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection. 2000 Transplantation pmid:10910279
MacDonald AS Management strategies for nephrotoxicity. 2000 Transplantation pmid:10910262
Fisher NC et al. The clinical impact of nephrotoxicity in liver transplantation. 2000 Transplantation pmid:10910259
Wang L et al. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo. 2000 Clin. Exp. Pharmacol. Physiol. pmid:10901387
Hishinuma S and Ogura K Ca(2+)/calmodulin-mediated regulation of the desensitizing process in G(q) protein-coupled histamine H(1) receptor-mediated Ca(2+) responses in human U373 MG astrocytoma cells. 2000 J. Neurochem. pmid:10899954
Mukerjee N et al. Caspase-mediated proteolytic activation of calcineurin in thapsigargin-mediated apoptosis in SH-SY5Y neuroblastoma cells. 2000 Arch. Biochem. Biophys. pmid:10898953
Yue G et al. The effect of rapamycin on single ENaC channel activity and phosphorylation in A6 cells. 2000 Am. J. Physiol., Cell Physiol. pmid:10898719
Mori A et al. Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: comparison of in vitro and in vivo effects between selective and nonselective cytokine synthesis inhibitors. 2000 J. Allergy Clin. Immunol. pmid:10887335
Hooijberg E et al. NFAT-controlled expression of GFP permits visualization and isolation of antigen-stimulated primary human T cells. 2000 Blood pmid:10887106
Arthur JM and Shamim S Interaction of cyclosporine and FK506 with diuretics in transplant patients. 2000 Kidney Int. pmid:10886578
Zaman AK Effects of tacrolimus hydrate (FK-506) on the expression of tissue factor in THP-1 human monocyte cell line. 2000 Hokkaido Igaku Zasshi pmid:10884973
Terashima A et al. Rapamycin and FK506 induce long-term potentiation by pairing stimulation via an intracellular Ca(2+) signaling mechanism in rat hippocampal CA1 neurons. 2000 Neuropharmacology pmid:10884573
Parker EM et al. Rapamycin, but not FK506 and GPI-1046, increases neurite outgrowth in PC12 cells by inhibiting cell cycle progression. 2000 Neuropharmacology pmid:10884572
Romano G et al. Systemic and intratubular effects of cyclosporin-A and tacrolimus on the rat kidney. 2000 Eur. J. Pharmacol. pmid:10884522
Ben Abraham R et al. [FK506 (tacrolimus) does not increase hepatic damage due to hypoperfusion]. 2000 Harefuah pmid:10883243
Hamazaki T et al. [Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors]. 2000 Rinsho Ketsueki pmid:10879106
Assmann T et al. Applications of tacrolimus for the treatment of skin disorders. 2000 Immunopharmacology pmid:10878290
Allison AC Immunosuppressive drugs: the first 50 years and a glance forward. 2000 Immunopharmacology pmid:10878284
Castilho RF et al. FK506 and cyclosporin A enhance the survival of cultured and grafted rat embryonic dopamine neurons. 2000 Exp. Neurol. pmid:10877919
Costantini LC and Isacson O Immunophilin ligands and GDNF enhance neurite branching or elongation from developing dopamine neurons in culture. 2000 Exp. Neurol. pmid:10877916
Morales JM et al. Immunosuppression in older renal transplant patients. 2000 Drugs Aging pmid:10874523
Queille-Roussel C et al. SDZ ASM 981 is the first non-steroid that suppresses established nickel contact dermatitis elicited by allergen challenge. 2000 Contact Derm. pmid:10871099
Au WY et al. Tacrolimus (FK 506) induced thrombotic thrombocytopenic purpura after ABO mismatched second liver transplantation: salvage with plasmapheresis and prostacyclin. 2000 Haematologica pmid:10870125
Neuhaus P et al. Quadruple tacrolimus-based induction therapy including azathioprine and ALG does not significantly improve outcome after liver transplantation when compared with standard induction with tacrolimus and steroids: results of a prospective, randomized trial. 2000 Transplantation pmid:10868638
Blakolmer K et al. Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging. 2000 Transplantation pmid:10868635
Yamani MH et al. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. 2000 Transplantation pmid:10868634
Oike F et al. A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine. 2000 Transplantation pmid:10868630
Wu K et al. The FK520 gene cluster of Streptomyces hygroscopicus var. ascomyceticus (ATCC 14891) contains genes for biosynthesis of unusual polyketide extender units. 2000 Gene pmid:10863099
Boubenider S et al. Interaction between theophylline and tacrolimus in a renal transplant patient. 2000 Nephrol. Dial. Transplant. pmid:10862651
Morelli AE et al. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus. 2000 J. Immunol. pmid:10861056
McLaughlin GE et al. Effect of aminophylline on urine flow in children with tacrolimus-induced renal insufficiency. 2000 Transplant. Proc. pmid:10856596
Malinowski K et al. Effect of different anti-rejection regimens on the expression of differentiation and activation markers on the surface of host lymphocytes. 2000 Transplant. Proc. pmid:10856579
Gotsman I et al. Effect of peripheral immune tolerance on liver-associated lymphocytes expressing NK1.1. 2000 Transplant. Proc. pmid:10856569
Barak S et al. Alveolar bone height in patients after liver transplantation. 2000 Transplant. Proc. pmid:10856558
Ben-Ari Z et al. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy. 2000 Transplant. Proc. pmid:10856553
Granot E et al. Monitoring of Epstein-Barr virus serology in children after liver transplant: lack of clinical correlation. 2000 Transplant. Proc. pmid:10856551
Bultynck G et al. Effects of the immunosuppressant FK506 on intracellular Ca2+ release and Ca2+ accumulation mechanisms. 2000 J. Physiol. (Lond.) pmid:10856121
Kochi S et al. Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin A and tacrolimus. 2000 Life Sci. pmid:10855946
Florio G et al. The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils. 2000 AIDS pmid:10853974
Rollins CT et al. A ligand-reversible dimerization system for controlling protein-protein interactions. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10852943
Schvarcz R et al. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). 2000 Transplantation pmid:10852623
Konrad T et al. Regulation of glucose tolerance in patients after liver transplantation: impact of cyclosporin versus tacrolimus therapy. 2000 Transplantation pmid:10852599
Gibson SW et al. Nutritional immunomodulation leads to enhanced allograft survival in combination with cyclosporine A and rapamycin, but not FK506. 2000 Transplantation pmid:10852592
Tyedmers J et al. Assembly of heterodimeric luciferase after de novo synthesis of subunits in rabbit reticulocyte lysate involves hsc70 and hsp40 at a post-translational stage. 2000 Eur. J. Biochem. pmid:10848974
Small bowel transplants in adults and multivisceral transplants in adults and children. 1999 Tecnologica MAP Suppl pmid:10848042
Zhang F et al. Resistance to Friend murine leukemia virus infection conferred by the Fv-4 gene is recessive but appears dominant from the effect of the immune system. 2000 J. Virol. pmid:10846105
Samsonov D et al. Enhancement of immune tolerance via induction of NK1.1 positive liver-associated-lymphocytes under immunosuppressive conditions. 2000 J. Hepatol. pmid:10845669
Nasr IS Topical tacrolimus in dermatology. 2000 Clin. Exp. Dermatol. pmid:10844509
Rabinowitz M et al. Solid-phase/solution-phase combinatorial synthesis of neuroimmunophilin ligands. 2000 Bioorg. Med. Chem. Lett. pmid:10843203
Yoshikawa T et al. In vivo osteogenic capability of cultured allogeneic bone in porous hydroxyapatite: immunosuppressive and osteogenic potential of FK506 in vivo. 2000 J. Bone Miner. Res. pmid:10841184
Oberholzer J et al. Daclizumab as escape therapy for late acute kidney rejection in the presence of FK506 nephrotoxicity. 2000 Transpl. Int. pmid:10836657
Higgins RM et al. Conversion from tacrolimus to cyclosporine in stable renal transplant patients: safety, metabolic changes, and pharmacokinetic comparison. 2000 Transplantation pmid:10836393
Moffatt SD and Metcalfe SM Comparison between tacrolimus and cyclosporine as immunosuppressive agents compatible with tolerance induction by CD4/CD8 blockade. 2000 Transplantation pmid:10836388
Chen H et al. Compromised kidney graft rejection response in Vervet monkeys after withdrawal of immunosuppressants tacrolimus and sirolimus. 2000 Transplantation pmid:10836361
Gallagher H et al. Post-transplantation lymphoproliferative disorder: an unusual presentation in a patient receiving tacrolimus. 2000 Nephrol. Dial. Transplant. pmid:10831670
Filler G et al. Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients. 2000 Nephrol. Dial. Transplant. pmid:10831643
Rerolle JP et al. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation. 2000 Clin Transplant pmid:10831087
Jindal RM and Dubernard JM Towards a specific immunosuppression for pancreas and islet grafts. 2000 Clin Transplant pmid:10831083
Blaheta RA et al. Mycophenolate mofetil decreases endothelial prostaglandin E2 in response to allogeneic T cells or cytokines. 2000 Transplantation pmid:10830246
Nakata Y et al. Tacrolimus and myocardial hypertrophy. 2000 Transplantation pmid:10830241
Eckhoff DE et al. The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. 2000 Transplantation pmid:10830224
Otley CC and Pittelkow MR Skin cancer in liver transplant recipients. 2000 Liver Transpl. pmid:10827224
Bang H et al. Prolyl isomerases in a minimal cell. Catalysis of protein folding by trigger factor from Mycoplasma genitalium. 2000 Eur. J. Biochem. pmid:10824113
Ortega-Pérez I and Redondo JM [The NFAT transcription factor family as immunosuppression target]. 2000 Nefrologia pmid:10822734
Wang JJ et al. Dimerization-dependent block of the proapoptotic effect of p75(NTR). 2000 J. Neurosci. Res. pmid:10820429
Küsters E et al. Purification of an ascomycin derivative with simulated moving bed chromatography. A case study. 2000 J Chromatogr A pmid:10817355
Przepiorka D et al. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1. 2000 Biol. Blood Marrow Transplant. pmid:10816027
Levy GA Neoral use in the liver transplant recipient. 2000 Transplant. Proc. pmid:10814745
McLaughlin GE et al. Use of phenobarbital in the management of acute tacrolimus toxicity: a case report. 2000 Transplant. Proc. pmid:10812158
Soran A et al. Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression. 2000 Transplant. Proc. pmid:10812157
Taber DJ et al. Drug-drug interaction between chloramphenicol and tacrolimus in a liver transplant recipient. 2000 Transplant. Proc. pmid:10812156
White SA et al. Randomized trial comparing neoral and tacrolimus immunousuppression for recipients of renal transplants procured from different donor groups. 2000 Transplant. Proc. pmid:10812132
Glanemann M et al. Higher immunosuppressive efficacy of mycophenolate mofetil in combination with FK 506 than in combination with cyclosporine A. 2000 Transplant. Proc. pmid:10812095
Chen XJ et al. Positive and negative control of multidrug resistance by the Sit4 protein phosphatase in Kluyveromyces lactis. 2000 J. Biol. Chem. pmid:10809730
Riley L et al. Cross-sensitivity reaction between tacrolimus and macrolide antibiotics. 2000 Bone Marrow Transplant. pmid:10808214
Pirsch J et al. Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability. 2000 J Clin Pharmacol pmid:10806606
Biggar SR and Crabtree GR Chemically regulated transcription factors reveal the persistence of repressor-resistant transcription after disrupting activator function. 2000 J. Biol. Chem. pmid:10801867
Adachi S et al. Successive expression and activation of NFAT family members during thymocyte differentiation. 2000 J. Biol. Chem. pmid:10799559
Moffatt SD et al. STAT 6 up-regulation by FK506 in the presence of interleukin-4. 2000 Transplantation pmid:10798785
Borger P et al. Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells. 2000 Transplantation pmid:10798763
Qi S et al. Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey. 2000 Transplantation pmid:10798741
Lu YM et al. Calcineurin-mediated LTD of GABAergic inhibition underlies the increased excitability of CA1 neurons associated with LTP. 2000 Neuron pmid:10798404
Gaweco AS et al. Intragraft localization of activated nuclear factor kappaB in recurrent hepatitis C virus disease following liver transplantation. 2000 Hepatology pmid:10796896
Kiani A et al. Manipulating immune responses with immunosuppressive agents that target NFAT. 2000 Immunity pmid:10795734
Yoshizawa K et al. Time-specific occurrence of alopecia in neonatal C57BL mice treated with N-methyl-N-nitrosourea and the therapeutic efficacy of tacrolimus hydrate. 2000 Pathol. Int. pmid:10792780
Ramsay HM and Harden PN Cyclosporin-induced flushing in a renal transplant recipient resolving after substitution with tacrolimus. 2000 Br. J. Dermatol. pmid:10792253
Neckermann G et al. Atopic dermatitis-like symptoms in hypomagnesaemic hairless rats are prevented and inhibited by systemic or topical SDZ ASM 981. 2000 Br. J. Dermatol. pmid:10792216
Katayama Y et al. [Studies on brain pyruvate dehydrogenase (PDH) activity and energy metabolites during ischemia and reperfusion]. 1999 Rinsho Shinkeigaku pmid:10791103
Kataoka T and Nagai K Involvement of FK506-sensitive and insensitive granule exocytosis pathways in perforin-dependent target cell lysis mediated by a CD8+ CTL clone. 2000 Immunol. Lett. pmid:10789681
Gonin JM Maintenance immunosuppression: new agents and persistent dilemmas. 2000 Adv Ren Replace Ther pmid:10782729
Vestergaard C et al. The NC/Nga mouse: a model for atopic dermatitis. 2000 Mol Med Today pmid:10782068
Chini EN and Walker H FK506 (tacrolimus) increases halothane-induced Ca2+ release from skeletal muscle sarcoplasmic reticulum. 2000 Anesthesiology pmid:10781282
Peters D et al. Potentiation of CD3-induced expression of the linker for activation of T cells (LAT) by the calcineurin inhibitors cyclosporin A and FK506. 2000 Blood pmid:10779414
Attur MG et al. Differential anti-inflammatory effects of immunosuppressive drugs: cyclosporin, rapamycin and FK-506 on inducible nitric oxide synthase, nitric oxide, cyclooxygenase-2 and PGE2 production. 2000 Inflamm. Res. pmid:10778917
Yamani MH et al. Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection. 2000 J. Heart Lung Transplant. pmid:10775813
Kraiss LW et al. Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in human endothelial cells. 2000 Am. J. Physiol. Heart Circ. Physiol. pmid:10775131
pmid:10773614
Outeda Macías M et al. Tacrolimus-itraconazole interaction in a kidney transplant patient. 2000 Ann Pharmacother pmid:10772445
Fernández-Miranda C et al. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid. 2000 Clin Transplant pmid:10770414
Klein BC et al. Influence of mycophenolic acid and FK-506 on human platelet activation in vitro. 2000 Kidney Blood Press. Res. pmid:10765114